Research at Berlin-Buch
The Berlin-Buch Campus is a unique site for medical research and development in Germany. The Max Delbrück Center for Molecular Medicine (MDC), founded in 1992 as a model for clinical research from three institutes of the GDR Academy of Sciences, was the initial driving force for the development of the campus into a research and biotechnology site of supraregional significance. Since 2000, the Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) has played a major role in this development.
Today, on the 32-hectare site which can look back on a long scientific tradition, institutes for basic medical research, research clinics and biotechnology companies are located in close proximity to each other. Buch's researchers, doctors and entrepreneurs are collaborating in the development of new treatments and diagnostic procedures for cancer, cardiovascular and nervous system diseases.
A modern Congress Center with integrated laboratories on the campus offers multiple opportunities for scientific interaction.
Enhanced speed, contrast, and information: New contrast mechanism improves xenon MRI
Xenon magnetic resonance imaging offers deep insights into the human body and opens up new possibilities in the diagnosis and treatment of diseases.more ...
A potent weapon against lymphomas
MDC researchers have developed a new approach to CAR T-cell therapy. The team has shown in Nature Communications that the procedure is very effective, especially when it comes to fighting follicular l...more ...
Integration of BIH into Charité and the privileged partnership with the MDC
On January 1, 2021, the Berlin Institute of Health (BIH) will become the translational research unit of Charité – Universitätsmedizin Berlinmore ...
GMP Biotech Summer School
Good Manufacturing Practice (GMP) Basic Course Biotechnology (English)more ...